搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
28 分钟
Ozempic's two lesser-known side effects impact your heart and skin
Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...
1 小时
on MSN
Josh Gad reveals he had to stop taking weight-loss drug due to side effects: ‘Really ...
Josh Gad has opened up for the first time about using GLP-1 medication for weight loss and his seesaw experience with the ...
2 小时
New study reveals what Americans perceive as ideal weight
Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...
21 小时
Oprah Winfrey shares the type of weight loss medication she took
Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...
C&EN
21 小时
Weight-loss start-up emerges from stealth
The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...
22 小时
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
1 天
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Medical News Today
1 天
A key protein may help Ozempic users retain muscle mass while losing fat
Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...
1 天
Weight Loss Revolution: New Breakthrough Could Prevent Muscle Loss While Shedding Pounds
Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...
BioPharma Dive
1 天
Versant invests again in obesity, this time backing Helicore Biopharma
Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive funding from Versant ...
emjreviews.com
1 天
GLP-1 Receptor Agonists Linked to Behavioural Side Effects
A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 ...
ohiocapitaljournal
1 天
Two Ohio doctors and their clinics disciplined over weight loss drugs
Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈